Focused on muscle and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Form
Filing Date
Mar 4, 2021
Document Date
Mar 1, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Dyne Therapeutics
Issuer
DYNE THERAPEUTICS, INC.
Filer
FARWELL WILDON